Tag: Antibodies

Latest News

Researchers isolate protective antibodies for rare, polio-like disease in children

Newsemia
Researchers at Vanderbilt University Medical Center, Purdue University and the University of Wisconsin-Madison have isolated human monoclonal antibodies that potentially can prevent a rare but...
Latest News

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

Newsemia
The current COVID-19 pandemic is still very much active in most parts of the world. In the absence of effective antiviral drugs or vaccines, scientists...
Latest News

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Newsemia
Now, a new Israeli study published on the preprint server bioRxiv in June 2020 reports a new recombinant vaccine expressing the S or spike protein...
Latest News

MMR vaccine could offer protection against COVID-19

Newsemia
Administering the MMR (measles, mumps, rubella) vaccine could serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection, say a team of...
Latest News

Coronavirus Study Suggests Antibodies May Last Only 2-3 Months After Infection

Newsemia
As per a new study, the coronavirus antibodies that a person may develop after recovering from COVID-19 may last for only two to three months....
Latest News

Researchers solve structure of key enzyme critical for biofilm formation in fungal pathogen

Newsemia
Aspergillus fumigatus is a species of fungus that can cause serious illnesses in immunocompromised individuals such as those who are undergoing transplantation or cancer chemotherapy....
Latest News

Tuberculosis and polio vaccines may offer temporary protection against SARS-CoV-2

Newsemia
As the world grapples with the coronavirus disease (COVID-19) pandemic, scientists race to develop an effective vaccine to protect against the deadly SARS-CoV-2 virus. While...
Latest News

Glycans "lock and load" the SARS-CoV-2 spike protein for infection

Newsemia
A new study by scientists from the University of California San Diego, USA and Maynooth University, Ireland and published on the preprint server bioRxiv* in...
Latest News

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

Newsemia
Researchers from France and the U.S. demonstrated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could induce an early and vigorous virus-specific IgA response...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World